ZOSTAVAX (Merck Sharp & Dohme Corp.)


Welcome to the PulseAid listing for the ZOSTAVAX drug offered from Merck Sharp & Dohme Corp.. This Live Attenuated Varicella Zoster Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Chickenpox Vaccine [Chemical/Ingredient],Live Attenuated Herpes Zoster Virus Vaccine [EPC],Herpes Zoster Vaccine [Chemical/Ingredient] pharmaceutical is classified as a VACCINE. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.

LABELER NAME / MANUFACTURER: Merck Sharp & Dohme Corp.
NON-PROPRIETARY NAME: Zoster Vaccine Live
SUBSTANCE NAME: VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN
TYPE: VACCINE
PHARMA CLASS: Live Attenuated Varicella Zoster Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Chickenpox Vaccine [Chemical/Ingredient],Live Attenuated Herpes Zoster Virus Vaccine [EPC],Herpes Zoster Vaccine [Chemical/Ingredient]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2006-05-25
END MARKETING DATE: 0000-00-00


ZOSTAVAX VACCINE Details:

Item DescriptionZOSTAVAX from Merck Sharp & Dohme Corp.
LABELER NAME: Merck Sharp & Dohme Corp.
DEA SCHEDULE:
ACTIVE STRENGTH: 19400([PFU]/.65mL)
START MARKETING DATE: 2006-05-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0006-4963_e4ce356e-321e-4709-a664-9a7c196a3237
PRODUCT NDC: 0006-4963
APPLICATION NUMBER: BLA125123

Other VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Merck Sharp & Dohme Corp.VARIVAX